RHÖN-KLINIKUM Aktiengesellschaft EBIT

As of the most recent data (June 2026), RHKJF shows a EBIT of $56M. That compares with $54M in the prior-year period — up 2.8% year over year. That is below the sector sector average of $2.5T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RHKJF's EBIT is now $56M (was $54M) — a 2.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether RHÖN-KLINIKUM Aktiengesellschaft is outperforming or lagging.

The its sector sector average EBIT is about $2.5T. RHÖN-KLINIKUM Aktiengesellschaft is at $56M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how RHKJF stacks up against individual peers as well.

Tracking RHKJF's ebit over time shows whether RHÖN-KLINIKUM Aktiengesellschaft is scaling, shrinking, or reshaping that part of the business. The current reading is $56M That compares with $54M in the prior-year period — up 2.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has RHÖN-KLINIKUM Aktiengesellschaft's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $56M) with ownership activity and broader fundamentals.